| 000 | 01498 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518074859.0 | ||
| 264 | 0 | _c20210621 | |
| 008 | 202106s 0 0 eng d | ||
| 022 | _a2164-554X | ||
| 024 | 7 |
_a10.1080/21645515.2019.1695459 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHollenberg, Rebecca K | |
| 245 | 0 | 0 |
_aSafety and immunogenicity of VGX-3100 formulations in a healthy young adult population. _h[electronic resource] |
| 260 |
_bHuman vaccines & immunotherapeutics _c06 2020 |
||
| 300 |
_a1404-1412 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntibodies, Viral |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHuman papillomavirus 16 |
| 650 | 0 | 4 | _aHuman papillomavirus 18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukocytes, Mononuclear |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xprevention & control |
| 650 | 0 | 4 | _aPapillomavirus Vaccines |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 | _aVaccines, DNA |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKrieger, Diane R | |
| 700 | 1 | _aSamuels, Robert | |
| 700 | 1 | _aKraynyak, Kim | |
| 700 | 1 | _aSylvester, Albert | |
| 700 | 1 | _aMorrow, Matthew | |
| 700 | 1 | _aBoyer, Jean | |
| 700 | 1 | _aDallas, Michael | |
| 700 | 1 | _aBhuyan, Prakash K | |
| 773 | 0 |
_tHuman vaccines & immunotherapeutics _gvol. 16 _gno. 6 _gp. 1404-1412 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/21645515.2019.1695459 _zAvailable from publisher's website |
| 999 |
_c30443314 _d30443314 |
||